The relationship between the epsilon 4 allele of the apolipoprotein E gene (APOE-ε4) located on chromosome 19 and Alzheimer's disease is well documented among Caucasian populations. However, the findings of research addressing the link between APOE polymorphism and neurocognitive functioning in populations of African origin from around the world have been equivocal. Therefore, the current study explored the relation of APOE-ε4 with cognitive impairment in a sample of community-dwelling English-speaking elderly blacks.
Methods:
All participants (N = 57) were recruited consecutively from a community memory-screening program at a University affiliated Memory Disorders Clinic and evaluated using standardized assessment procedures. Cognitive impairment was classified according to an age and education adjusted Mini-Mental State Exam score of less than 24 as well as poorer functioning on a measure of delayed verbal memory.
Results:
Increased risk for global cognitive dysfunction (OR = 9.5, 95 percent CI = 2.3–55.3, p = .004) and poorer verbal recall performance (β = −.36, p = .006) were linked with the APOE ε4 allele after controlling for the potentially confounding effects of age, education, and gender.
Conclusions:
This investigation supports the role of APOE polymorphism in determining neurocognitive impairment among black elders residing in the community.
LarsonEBKukullWAKatzmanRL. Cognitive impairment: Dementia and Alzheimer's disease. Annual Review of Public Health1992;13:431–449.
2.
Agüero-TorresHFratiglioniLGuoZViitanenMvon StraussEWinbladB. Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. American Journal of Public Health1998;88:1452–1456.
3.
OsterweilDMartinMSyndulkoK. Predictors of skilled nursing placement in a multilevel long-term-care facility. Journal of the American Geriatrics Society1995;43:108–112.
4.
SchulzRO'BrienATBookwalaJFleissnerK. Psychiatric and physical morbidity effects of dementia caregiving: Prevalence, correlates, and causes. Gerontologist1995;35:771–791.
5.
YeoGGallagher-ThompsonDLiebermanM. Variations in dementia characteristics by ethnic category. In: YeoGGallagher-ThompsonD, editors. Ethnicity and the dementias. Washington, DC: Taylor & Francis, 1996:21–30.
6.
GurlandBJWilderDELantiguaRSternYChenJKillefferEHMayeuxR. Rates of dementia in three ethnoracial groups. International Journal of Geriatric Psychiatry1999;14:481–493.
7.
HarwoodDGOwnbyRL. Ethnicity and dementia. Current Psychiatry Reports2000;2:40–45.
8.
Aging America: Trends and Projections. Washington, DC: U.S. Senate, 1991. U.S. Department of Health and Human Services.
9.
CallahanCMHallKSHuiSLMusickBSUnverzagtFWHendrieHC. Relationship of age, education, and occupation with dementia among a community-based sample of African Americans. Archives of Neurology1996;53:134–140.
10.
HallKSGurejeOGaoSOgunniyiAHuiSLBaiyewuOUnverzagtFWOluwoleSHendrieHC. Risk factors and Alzheimer's disease: A comparative study of two communities. Australian and New Zealand Journal of Psychiatry1998;32:698–706.
11.
HallKSGaoSUnverzagtFWHendrieHC. Low education and childhood rural residence: Risk for Alzheimer's disease in African Americans. Neurology2000;54:95–99.
12.
FarrerLACupplesLAHainesJLHymanBKukullWAMayeuxRMyersRHPericak-VanceMARischNvan DuijnCM. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and Alzheimer disease: A meta-analysis. Journal of the American Medical Association1997;278: 1349–1356.
13.
PlassmanBLBreitnerJCS. The genetics of dementia in late life. Psychiatric Clinics of North America1997;20:59–76.
14.
TangM-XMaestreGTsaiW-YLiuX-HFengLChungW-YChunMSchofieldPSternYTyckoBMayeuxR. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. American Journal of Human Genetics1996;58:574–584.
15.
SahotaAYangMGaoSHuiSLBaiyewuOGurejeOOluwoleSOgunniyiAHallKSHendrieHC. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent. Annals of Neurology1997;42:659–661.
16.
OsuntokunBOSahotaAOgunniyiAOGurejeOBaiyewuOAdeyinkaAOluwoleSOKomolafeOHallKSUnverzagtFWHuiSLYangMHendrieHC. Lack of association between apolipoprotein E ε4 and Alzheimer's disease in elderly Nigerians. Annals of Neurology1995;38:463–465.
17.
MorganOSEldemireDAThesigerCHLusekoJSahotaAGaoSHallKSHendrieHC. APOE allele frequencies in demented and nondemented elderly Jamaicans. Archives of Neurology1998;43:545.
18.
TangMSternYMarderKBellKGurlandBLantiguaRAndrewsHFengLTyckoBMayeuxR. The APOE ε allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. Journal of the American Medical Association1998;279:751–755.
19.
EvansRMEmsleyCLGaoSSahotaAHallKSFarlowMRHendrieHC. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population based study of African Americans. Neurology2000;54:240–242.
20.
SlooterAJTangMXvan DuijnCMSternYOttABellKBretelerMMVan BroeckhovenCTatemichiTKTyckoBHofmanAMayeuxR. Apolipoprotein E epsilon 4 and the risk for dementia with stroke. A population-based investigation. Journal of the American Medical Association1997;277:818–821.
21.
JiYUrakamiKAdachiYMaedaMIsoeKNakashimaK. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dementia and Geriatric Cognitive Disorders1998;9: 243–245.
22.
MarinDBBreurBMarinMLSilvermanJSchmeidlerJGreenbergDFlynnSMareMLantzMLibowLNuefeldRAltstielLDavisKLMohsRC. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis1998;140:173–180.
23.
HuiSLGaoSHallKSSahotaAHendrieHC. Association of the ε4 allele of apolipoprotein E with poor performance on a dementia screen in African Americans. Ethnicity and Disease1996;6:266–271.
24.
StewartRRussCRichardsMBrayneCLovestoneSMannA. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dementia and Geriatric Cognitive Disorders2001;12:251–256.
25.
KullerLHShemanskiLManolioTHaanMFriedLBryanNBurkeGLTracyRBhadeliaR. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke1998;29:388–398.
26.
GauthierMAClarkeWP. Gaining and sustaining minority participation in longitudinal research projects. Alzheimer Disease and Associated Disorders1999;13(Suppl. 1):S29–S33.
27.
FolsteinMFolsteinSMcHughP. ‘Mini-Mental State.’ A practical method for grading the cognitive state of patients for the physician. Journal of Psychiatric Research1975;12:189–198.
28.
TsaiLTsuangMT. The Mini Mental State test and computerized tomography. American Journal of Psychiatry1979;136:436–438.
29.
FillenbaumGHeymanAWilliamsKProsnitzBBurchettB. Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. Journal of Clinical Epidemiology1990;43:651–660.
30.
GurlandBJWilderDECrossPTeresiJBarrettVW. Screening scales of dementia: Toward reconciliation of conflicting cross-cultural findings. International Journal of Geriatric Psychiatry1992;7:105–113.
31.
MungasDMarshallSCWeldonMHaanHReedBR. Age and education correction of the Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology1996;46:700–706.
32.
LoewensteinDABarkerWWHarwoodDGLuisCAcevedoARodriguezIDuaraR. Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community-dwelling elders. International Journal of Geriatric Psychiatry2000;15:434–440.
33.
WenhamPRPriceWHBlundellG. Apolipoprotein E genotyping by one stage PCR. Lancet1991;337:1158–1159.
34.
ZekraouiLLucotteGRaisonnierA. Apolipoprotein E genotypes in Africa: Allelic frequencies and ethnic groups. Paper presented at the Ibsen Foundation Meeting, Paris, May 29, 1995.
35.
KambohMISepehrniaBFerrellRE. Genetic studies of human lipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. Disease Markers1989; 7:49–55.
36.
SrinivasanSREhnholmCWattigneyWBerensonGS. Apolipoprotein E polymorphism with serum lipoprotein concentrations in black versus white children: The Bogalusa Heart Study. Metabolism1993;42:381–386.
37.
Pablos-MendezAMayeuxRNgaiCSheaSBerglundL. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arteriosclerosis, Thrombosis, and Vascular Biology1997;17:3534–3541.
38.
SkoogIHesseCAevarssonOLandahlSWahlstromJFredmanPBlennowK. A population study of apoE genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality. Journal of Neurology, Neurosurgery and Psychiatry1998;64:37–43.
39.
KnopmanDSRybergS. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Archives of Neurology1989;46:141–145.
40.
JacobsDMSanoMDooneiefGMarderKBellKLSternY. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology1995;45:957–962.
41.
LinnRTWolfPABachmanDLKnoefelJECobbJLBelangerAJKaplanEFD'AgostinoRB. The ‘preclinical phase’ of probable Alzheimer's disease. Archives of Neurology1995;52:485–490.
42.
LocascioJJGrowdonJHCorkinS. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Archives of Neurology1995;52:1087–1099.
43.
PrineasRJDemirovicJBeanJADuaraRGómez-MarínOLoewensteinDSevushSStittFSzapocznikJ. South Florida Program on Aging and Health: Assessing the prevalence of Alzheimer's disease in three ethnic groups. Journal of the Florida Medical Association1995;82:805–810.
44.
HeymanAFillenbaumGProsnitzBRaifordKBurchettBClarkC. Estimated prevalence of dementia among elderly black and white community residents. Archives of Neurology1991;48:594–598.
45.
DeviGOttmanRTangMMarderKSternYTyckoBMayeuxR. Influence of APOE genotype on familial aggregation of AD in an urban population. Neurology1999;53:789–794.
